Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of Cryptococcus neoformans in a murine modelDEVI, S. J. N.Vaccine. 1996, Vol 14, Num 9, pp 841-844, issn 0264-410XArticle

Salmonella carriage rate amongst school children : a three year studyDEVI, S. J. N; MURRAY, C. J.Southeast Asian journal of tropical medicine and public health. 1991, Vol 22, Num 3, pp 357-361, issn 0125-1562Article

Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeysDEVI, S. J. N; ZOLLINGER, W. D; SNOY, P. J et al.Infection and immunity. 1997, Vol 65, Num 3, pp 1045-1052, issn 0019-9567Article

Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccinesZOLLINGER, W. D; MORAN, E. E; DEVI, S. J. N et al.Infection and immunity. 1997, Vol 65, Num 3, pp 1053-1060, issn 0019-9567Article

Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus : construction, immunogenicity, and protective efficacy in a murine modelDEVI, S. J. N; HAYAT, U; FRASCH, C. E et al.Infection and immunity. 1995, Vol 63, Num 8, pp 2906-2911, issn 0019-9567Article

Serological evaluation of brucellosis: importance of species in antigen preparationDEVI, S. J. N; POLT, S. S; BOCTOR, F. N et al.The Journal of infectious diseases. 1987, Vol 156, Num 4, pp 658-661, issn 0022-1899Article

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines : synthesis, characterization and immunologyDEVI, S. J. N; XCHNEERSON, R; EGAN, W et al.Infection and immunity. 1991, Vol 59, Num 10, pp 3700-3707, issn 0019-9567Article

Detection and quantitation of the glucuronoxylomannan-like polysaccharide antigen from clinical and nonclinical isolates of Trichosporon beigelii and implications for pathogenicityLYMAN, C. A; DEVI, S. J. N; NATHANSON, J et al.Journal of clinical microbiology (Print). 1995, Vol 33, Num 1, pp 126-130, issn 0095-1137Article

Antibodies to poly[(2→8)-α-N-acetylneuraminic acid] and poly[(2→9)-α-N-acetyleuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates : potential vaccines for groups B and C meningococci and E. coli K1DEVI, S. J. N; ROBBINS, J. B; SCHNEERSON, R et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 16, pp 7175-7179, issn 0027-8424Article

Preclinical immunoprophylactic and immunotherapeutic efficacy of antisera to capsular polysaccharide-tetanus toxoid conjugate vaccines in Vibrio vulnificusDEVI, S. J. N; HAYAT, U; POWELL, J. L et al.Infection and immunity. 1996, Vol 64, Num 6, pp 2220-2224, issn 0019-9567Article

Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infectionCASADEVALL, A; MUKHERJEE, J; DEVI, S. J. N et al.The Journal of infectious diseases. 1992, Vol 165, Num 6, pp 1086-1093, issn 0022-1899Article

Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and escherichia coli K1 non-o acethylatedDEVI, S. J. N; SCHNEERSON, R; EGAN, W et al.Infection and immunity. 1991, Vol 59, Num 2, pp 732-736, issn 0019-9567Article